Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Sometimes the retraction of a paper can be as noteworthy as the publication of one. Here we list some of the take-backs of 2010 that left the biomedical community most taken aback.
The recent global campaign launched against a select number of neglected tropical diseases (NTDs) is a welcome development. But we should be as careful about measuring progress toward the control or elimination of these diseases as we are about choosing which ones to target.
Here's the skinny on the weight loss drugs that disappointed, the hepatitis drugs that matched the hype and others as we look back on the major headlines relating to medications in 2010.